Release Date: 06/04/20 08:16 Summary: Renounceable Entitlement Issue Prospectus Price Sensitive: Yes Download Document 427.99KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%